Evidence map›Paper›PMID 35012679›Full record

ArticleAntimicrobial resistance and infection control2022

Healthcare institutions' recommendation regarding the use of FFP-2 masks and SARS-CoV-2 seropositivity among healthcare workers: a multicenter longitudinal cohort study.

Katarzyna Szajek, Felix Fleisch, Sandra Hutter, Martin Risch, Theresa Bechmann, Valerie A Luyckx, Sabine Güsewell, Cédric Hirzel, Alexia Cusini, Amico Study Group and 1 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Antimicrobial resistance and infection control, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Transmission and Risk Factors of COVID-19 among Health Care Workers.Seminars in respiratory and critical care medicine · 2023
    Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Katarzyna SzajekDepartment of Internal Medicine, Cantonal Hospital of Grisons, Chur, Switzerland.
Felix FleischDivision of Infectious Diseases, Cantonal Hospital of Grisons, 7000, Chur, Switzerland.
Sandra HutterCentral Laboratory, Cantonal Hospital of Grisons, Chur, Switzerland.
Martin RischCentral Laboratory, Cantonal Hospital of Grisons, Chur, Switzerland.
Theresa BechmannDivision for Information and Communication Technology, Cantonal Hospital of Grisons, Chur, Switzerland.
Valerie A LuyckxDivision of Nephrology, Cantonal Hospital of Grisons, Chur, Switzerland.
Sabine GüsewellClinical Trials Unit, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland.
Cédric Hirzel *Department of Infectious Diseases and Hospital Epidemiology, University Hospital and University of Bern, Bern, Switzerland.
Alexia Cusini *Division of Infectious Diseases, Cantonal Hospital of Grisons, 7000, Chur, Switzerland. alexia.cusini@ksgr.ch.
Amico Study Group
AMICO Study Group
Pädagogische Hochschule Graubünden · CHUniversity of Applied Sciences of the Grisons · CHUniversity of Bern · CHUniversity of St.Gallen · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHealth care workers (HCW) are heavily exposed to SARS-CoV-2 from the beginning of the pandemic. We aimed to analyze risk factors for SARS-CoV-2 seroconversion among HCW with a special emphasis on the respective healthcare institutions' recommendation regarding the use of FFP-2 masks.

methodsWe recruited HCW from 13 health care institutions (HCI) with different mask policies (type IIR surgical face masks vs. FFP-2 masks) in Southeastern Switzerland (canton of Grisons). Sera of participants were analyzed for the presence of SARS-CoV-2 antibodies 6 months apart, after the first and during the second pandemic wave using an electro-chemiluminescence immunoassay (ECLIA, Roche Diagnostics). We captured risk factors for SARS-CoV-2 infection by using an online questionnaire at both time points. The effects of individual COVID-19 exposure, regional incidence and FFP-2 mask policy on the probability of seroconversion were evaluated with univariable and multivariable logistic regression.

resultsSARS-CoV-2 antibodies were detected in 99 of 2794 (3.5%) HCW at baseline and in 376 of 2315 (16.2%) participants 6 months later. In multivariable analyses the strongest association for seroconversion was exposure to a household member with known COVID-19 (aOR: 19.82, 95% CI 8.11-48.43, p < 0.001 at baseline and aOR: 8.68, 95% CI 6.13-12.29, p < 0.001 at follow-up). Significant occupational risk factors at baseline included exposure to COVID-19 patients (aOR: 2.79, 95% CI 1.28-6.09, p = 0.010) and to SARS-CoV-2 infected co-workers (aOR: 2.50, 95% CI 1.52-4.12, p < 0.001). At follow up 6 months later, non-occupational exposure to SARS-CoV-2 infected individuals (aOR: 2.54, 95% CI 1.66-3.89 p < 0.001) and the local COVID-19 incidence of the corresponding HCI (aOR: 1.98, 95% CI 1.30-3.02, p = 0.001) were associated with seroconversion. The healthcare institutions' mask policy (surgical masks during usual exposure vs. general use of FFP-2 masks) did not affect seroconversion rates of HCW during the first and the second pandemic wave.

conclusionContact with SARS-CoV-2 infected household members was the most important risk factor for seroconversion among HCW. The strongest occupational risk factor was exposure to COVID-19 patients. During this pandemic, with heavy non-occupational exposure to SARS-CoV-2, the mask policy of HCIs did not affect the seroconversion rate of HCWs.

Indexed as

Health PersonnelMasksPandemicsSARS-CoV-2AdultAntibodies, ViralCohort StudiesCOVID-19FemaleHumansLongitudinal StudiesMaleMiddle AgedProspective StudiesRisk FactorsSeroconversionAntibodies, ViralFFP-2 and surgical masksHealthcare workersMask policySARS-CoV-2Seroconversion

Identifiers

PMID35012679
PMCPMC8744038
OpenAlexW4205288856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.